These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24277985)

  • 1. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.
    Kim J; Rhee CK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Oh Y; Lee SD; Kim Y; Kim K; Yoon H
    Int J Chron Obstruct Pulmon Dis; 2013; 8():561-8. PubMed ID: 24277985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea.
    Kim C; Yoo KH; Rhee CK; Yoon HK; Kim YS; Lee SW; Oh YM; Lee SD; Lee JH; Kim KJ; Kim JH; Park YB
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):737-43. PubMed ID: 24903947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function.
    Lim JU; Kim K; Kim SH; Lee MG; Lee SY; Yoo KH; Lee SH; Jung KS; Rhee CK; Hwang YI
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2711-2721. PubMed ID: 28979113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma.
    Rhee CK; Yoon HK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Kim Y; Kim K; Kim J; Oh YM; Lee SD
    COPD; 2014 Apr; 11(2):163-70. PubMed ID: 24111662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and predictors of the cost of COPD in primary care: a Spanish perspective.
    de Miguel Diez J; Carrasco Garrido P; García Carballo M; Gil de Miguel A; Rejas Gutierrez J; Bellón Cano JM; Hernández Barrera V; Jimenez García R
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):701-12. PubMed ID: 19281084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of chronic obstructive pulmonary disease from 2004 to 2013.
    Kim J; Lee TJ; Kim S; Lee E
    J Med Econ; 2016; 19(2):103-10. PubMed ID: 26414920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K; Sun SX; Ellis JJ; Howe A; Amin A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.
    Stephenson JJ; Wertz D; Gu T; Patel J; Dalal AA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1947-1959. PubMed ID: 28740375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice.
    Seifer FD; Hansen G; Weycker D
    Chron Respir Dis; 2019; 16():1479973119839961. PubMed ID: 30961354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural course of early COPD.
    Rhee CK; Kim K; Yoon HK; Kim JA; Kim SH; Lee SH; Park YB; Jung KS; Yoo KH; Hwang YI
    Int J Chron Obstruct Pulmon Dis; 2017; 12():663-668. PubMed ID: 28255237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
    Punekar YS; Shukla A; Müllerova H
    Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.
    Sadatsafavi M; Tavakoli H; Kendzerska T; Gershon A; To T; Aaron SD; FitzGerald JM;
    Ann Am Thorac Soc; 2016 Feb; 13(2):188-96. PubMed ID: 26599154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of asthma and COPD overlap.
    Kim MH; Rhee CK; Kim K; Kim SH; Lee JY; Kim YH; Yoo KH; Cho YJ; Jung KS; Lee JH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1251-1260. PubMed ID: 29713158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.